Načítá se...
Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy.
SYA16263 exhibited moderate radioligand binding affinity at the D(2) receptor and produced inhibition of apomorphine-induced climbing behavior in mice with an ED(50) value of 3.88 mg/kg IP, predicting potential antipsychotic effects in humans. Analysis of plasma and brains from rats injected IP with...
Uloženo v:
| Vydáno v: | Pharmacol Biochem Behav |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581196/ https://ncbi.nlm.nih.gov/pubmed/30768942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2019.02.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|